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Sir
With great interest, I read the different results found for birth
weight and birth length on adult breast cancer risk reported by
Vatten (2002) and Sanderson (2002). Both articles referred to a
hypothesis on early through postconception life events and breast
cancer risk (Trichopoulos, 1990). In addition, Vatten found no
relation between placenta weight and breast cancer risk. I wonder
whether an alternative explanation, which relates to the mother’s
age at birth, would have given more consistent results across the
two studies. Several hypotheses on the role of postconception
early-life events and adult disease risk seem equally compatible
with a preconception hypothesis on qualities of the oocyte
reflected by maternal age at conception/birth (van Noord, 2002).
I developed this hypothesis in an attempt to unify de Waard’s
early-life hypothesis (de Waard, 1988) with Trichopoulos’ (1990)
and Barker’s (1993) intrauterine hypotheses. All three hypotheses
rely heavily on an adequate energy production for human growth,
essential for any maturation or development.
The viability of oocytes seems to be codetermined by the quality
of their mitochondria and the related production of energy/ATP,
which is known to decline with age and ageing (Papa, 1996; Ozawa,
1997). The importance of viable mitochondria at conception is
illustrated by in vitro fertilisations where successful implantation,
among biologically older women, became possible again when
their own less viable oocytes were coinjected upon conception with
mitochondria from a younger mother (Barritt, 2001). Repopulation
of cells by heteroplasmic mitochondrial DNA (mtDNA) and
relations with cell ‘ageing’ was observed before (King, 1989).
In the hypothesis, I propose that maternal age at birth (and
conception) actually reflects the quality of the mitochondria with
which an individual begins his or her life. This preconceptional
mitochondrial hypothesis can also account for the opposing effects
on carcinogenesis of caloric restriction and the role of free radicals
that spill from the Krebs’s cycle, as both relate to the proper
functioning of the energy production by the mitochondria
(Beckman, 1998; Merry, 2002). This also may be linked to the
phenomena of selective cell death like spontaneous abortion early
and apoptosis later in life (Hengartner, 2000).
The role of mitochondria is relevant to the interpretation of the
results of Vatten because they play such an essential role in cell
metabolism through their production of energy/ATP. The correla-
tion of maternal age at birth with mitochondrial viability would
link a subcellular phenomena to those observable at the level of
populations as can be studied by epidemiology. Several (breast)
cancer risk factors in adult life such as adult height, age at
first childbirth, BMI, age at natural menopause and breast
dysplasia, show some correlation with maternal age at birth
(van Noord, 2001; van Noord, 2002).
Maternal age at birth may represent not just the biological age of
the maternal oocyte, but may also reflect the age of the mother’s
mother (the maternal grandmother), where the initial meiotic
cleavage of such an oocyte occurred (Warburton, 1997). From this
meiosis-I time onwards, the mtDNA would have started to
accumulate mutations even in the resting nondividing oocyte, since
circular mtDNA as opposed to nucleair DNA lacks protection by
histones or DNA repair (Attardi, 1981; Borst, 1981; Wallace, 1989).
There are reasons to believe that all these periconceptional
phenomena represent purely maternal-, and not paternal-inherited
epigenetic aspects that operate well before another maternal factor,
the postimplantation placenta-dependent intrauterine environ-
ment, of Trichopoulos’ hypothesis can play a role. This is evident
by the lack of correlation between placenta weight and breast
cancer risk reported by Vatten (2002). The placenta as a
predominantly foetal organ (Susser, 1982) depends for its growth
on paternal genes active in the blastocyst, especially the IGF-2
gene, which becomes expressed only around nidation (Ferguson,
2001). Before this time the paternal IGF-2 gene is silenced by
imprinting an epigenetic process that starts immediately after
conception and is finished before the first mitosis of the zygote
(Oudejans, 1997). Thus a placenta can only have played a role long
after imprinting and gastrulation, when by then the most crucial
first cell cycles have already taken place (Wolpert, 1991). All these
processes from conception, transport in the oviduct until nidation
and until placentation, cover at least the first five cell divisions,
and have by then resulted in at least 32 (2
5) cells that cover 10% of
all the 50 divisions an embryonic cell can make in a human lifetime
(Hayflick, 1961). These first divisions and this initial cell mass
were purely dependent on preconception maternal factors that
during follicle growth have determined the nutrient and energy
stores in the ooplasm and the number of mitochondria in the
oocyte before ovulation. Thereafter, the viability of and the
number of mitochondria per oocyte are crucial for ATP
production required for all these early, highly energy-dependent
processes (Wilson, 1992) as well as all growth after placentation. In *Correspondence: PAH van Noord; E-mail: P.A.H.vanNoord@jc.azu.nl
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of other essential nutrients on the proper functioning of the
respiratory enzymes of the mitochondrial membrane-bound
Kreb’s cycle. Such nutrients can mend deficiencies, either in
specific diseases (Eleff, 1984) or enzyme deficiencies accumulating
with age(ing) (Ames, 2002). Suboptimal energy production by less
viable mitochondria may, for example, affect the correct function-
ing of the cell spindle required for proper chromosome separation
during these first five cell divisions, resulting either in abortion or
when the fertilized egg survives, aneuploidy in the foetus and
related birth defects.
The increases in aneuploidy run parallel to the decline in
fecundity in biologically older mothers (van Noord-Zaadstra,
1999). In the surviving foetuses carrying aneuploidy and/or a
higher propensity to aneuploidy, a high maternal age is reflected in
an increased risk of several cancers in their offspring (Abelin,
1965). From this perspective of defective growth and development,
it is interesting that aneuploidy is also an essential trait of cancer
cells, as described already more than hundred years ago by Boveri
(Deusberg, 1998). Also in adult cells and tissues, mitochondria play
a pivoting role in proper cell function. Improper functioning cells
can be eliminated selectively by apoptosis in which mitochondria
also play a cruxial role (Hengartner, 2000) or when escaping
apoptosis, show signs of aneuploidy and become cancerous
(Deusberg, 1998).
Birth weight and length at birth have not only been linked to
IGF-2 but also to IGF-1. A role of the IGF-1 axis on breast cancer,
however, has only been found for premenopausal breast cancers
(Bruning, 1995). Since birth weight effects on breast cancer risk
were described both in pre- as well as in postmenopausal breast
cancers, IGF-1 levels seem a less likely candidate to explain the
inconsistent findings on birth weight and breast cancer risk in the
literature. Hence, my oocyte hypothesis on how cancer risk and
birth weight may both be maternally codetermined, not only by
late intrauterine factors, but also by early epigenetic transmitted
mitochondria, preceding conception and through their influence
on proper energy production, may reconcile discrepant findings
between birth weight and cancer risk.
Reanalysis of the data by Vatten and possibly also the data of
Sanderson, using maternal age at birth instead of birth
weight could test whether and, if so, to what extent, this
preconception hypothesis on the role of mitochondria required
for optimal cell function could better explain subsequent cancer
risks.
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